Clinical Trials Logo

Clinical Trial Summary

Patients' and healthcare professionals' experience of using Apple iPads to conduct patient and public involvement activity


Clinical Trial Description

There is a long overdue push to get patients engaged at the earliest stage possible of the research cycle so there is earlier collaboration between the public/patients and the researcher rather than much later on in the research process. For this reason there are successful patient and public meetings that occur in various specialities within the NHS. However, attending these meetings can be difficult as timings for multiple people to attend at the same physical location can be logistically difficult. It can be further compounded if potential members are unable to attend due to their illness. For example, patients may be on home oxygen and therefore may not be selected by the facilitator or perhaps they themselves may decide to exclude themselves. Previous research has had an online forum to engage the public/patients with the research process. However, the findings were that there was room to improve from an engagement perspective and furthermore, the real-time communication was limited due to how forums functions. For this reason, the investigators have suggested using iPads so the investigators can have virtual meetings which negates the need to attend meetings physically. The investigators have used iPads instead of other tablets due to their higher encryption standards and because the in-built FaceTime is easier to use than other systems that install a separate application. Virtual meetings where a group of people are not in the same physical location and are communicating via telephone or the internet. Many patients who may not have been considered/been approached about being part of PPI can now participate virtually. In addition, the time commitment is significantly reduced as it would only involve the time the meeting would be held and not the travel time, which can be extensive. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05953805
Study type Observational
Source Nottingham University Hospitals NHS Trust
Contact
Status Completed
Phase
Start date February 11, 2019
Completion date August 11, 2021

See also
  Status Clinical Trial Phase
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device